NASDAQ:CASI
CASI Pharmaceuticals Stock News
$2.80
+0.115 (+4.29%)
At Close: May 03, 2024
CASI Pharmaceuticals Announces Second Quarter 2020 Financial Results
11:01am, Monday, 10'th Aug 2020CASI Pharmaceuticals Announces Second Quarter 2020 Financial Results
11:00am, Monday, 10'th Aug 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial resu
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
CASI Pharmaceuticals Inc (NASDAQ:CASI) CEO Buys $5,609,609.40 in Stock
04:12am, Monday, 27'th Jul 2020
CASI Pharmaceuticals Inc (NASDAQ:CASI) CEO Wei-Wu He purchased 2,952,426 shares of the company’s stock in a transaction dated Wednesday, July 22nd. The shares were purchased at an average cost of $1
Week In Review: BeiGene Signs $540 Million Deal For China Rights To 3 HBV Candidates
12:07pm, Sunday, 26'th Jul 2020
Beijing's BeiGene in-licensed Greater China rights to three inhibitors for chronic hepatitis B virus from Assembly Biosciences in a $540 million agreement.
CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common Stock
01:05pm, Wednesday, 22'nd Jul 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the pricing o
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock
08:01pm, Tuesday, 21'st Jul 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has c
Here's What CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shareholder Ownership Structure Looks Like
01:39pm, Thursday, 09'th Jul 2020
A look at the shareholders of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) can tell us which group is most powerful...
2020 Insights into the Global Multiple Myeloma Market and Competitive Landscape - ResearchAndMarkets.com
12:00am, Friday, 26'th Jun 2020
The
CASI Pharmaceuticals Submits a Clinical Trial Application in the UK for a Phase 1 Study of its Anti-38 Monoclonal
11:03am, Monday, 08'th Jun 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it submi
CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
11:00am, Tuesday, 02'nd Jun 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-
Do Hedge Funds Love CASI Pharmaceuticals Inc (CASI)?
09:38pm, Sunday, 31'st May 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Wei-Wu He Is The Chairman & CEO of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) And They Just Picked Up 32% More Shares
10:14am, Monday, 25'th May 2020
Those following along with CASI Pharmaceuticals, Inc. (NASDAQ:CASI) will no doubt be intrigued by the recent purchase...
